| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C25H27FN2O |
| Molar mass | 390.502 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5F-CUMYL-PEGACLONE (5F-SGT-151,SGT-269) is agamma-carboline basedsynthetic cannabinoid that has been sold as adesigner drug, first being identified in Germany in 2017. It acts as a potent full agonist of the CB1 receptor.[1][2] It appears to be more toxic than related compounds such asCUMYL-PEGACLONE, and has been linked to numerous serious adverse reactions, some fatal.[3]
Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |